IMKTA vs REGN · P/E 20, rev $5.33B vs P/E 14, rev $4.29B
Ingles Markets Incorporated (IMKTA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Ingles Markets Incorporated (IMKTA) is a grocery stores company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported IMKTA revenue for 2025-09-27 was $5.33B. Net income was $83.6M. IMKTA currently screens at market cap $1.25B and trailing P/E 20.2.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
IMKTA currently screens at market cap $1.25B and trailing P/E 20.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the IMKTA and REGN stock pages for the full models.
Not investment advice.